{"id":"https://openalex.org/W6973382","doi":null,"title":"[Efficacy and safety of memantine in dementia with Lewy bodies].","display_name":"[Efficacy and safety of memantine in dementia with Lewy bodies].","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W6973382","mag":"6973382","pmid":"https://pubmed.ncbi.nlm.nih.gov/18577956"},"language":"ru","primary_location":{"id":"pmid:18577956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18577956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077041978","display_name":"Oleg Semenovich Levin","orcid":"https://orcid.org/0000-0003-3872-5923","observed_orcids":["https://orcid.org/0000-0003-3872-5923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O S Levin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066939128","display_name":"L. A. Batukaeva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L A Batukaeva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042132392","display_name":"\u0421\u043c\u043e\u043b\u0435\u043d\u0446\u0435\u0432\u0430 \u0418\u0440\u0438\u043d\u0430 \u0413\u0435\u043d\u043d\u0430\u0434\u044c\u0435\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0002-5569-6688","observed_orcids":["https://orcid.org/0000-0002-5569-6688"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I G Smolentseva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110351520","display_name":"\u041d. \u0410. \u0410\u043c\u043e\u0441\u043e\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N A Amosova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2175,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.57410343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"108","issue":"5","first_page":"39","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8090999722480774,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.17350000143051147,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/dementia-with-lewy-bodies","display_name":"dementia with Lewy bodies","score":1.0},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.656000018119812},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.4399999976158142},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cognitive-fluctuations","display_name":"cognitive fluctuations","score":0.5870000123977661},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.48500001430511475},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5529999732971191},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.8780760765075684},{"id":"https://openalex.org/C2778548049","wikidata":"https://www.wikidata.org/wiki/Q101245788","display_name":"Dementia with Lewy bodies","level":4,"score":0.8664824366569519},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8009592890739441},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.6225606203079224},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5520579218864441},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.5491131544113159},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5265876650810242},{"id":"https://openalex.org/C2777952318","wikidata":"https://www.wikidata.org/wiki/Q583908","display_name":"Vascular dementia","level":4,"score":0.4737620949745178},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.45452606678009033},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45275402069091797},{"id":"https://openalex.org/C2779753318","wikidata":"https://www.wikidata.org/wiki/Q160796","display_name":"Delirium","level":2,"score":0.446934312582016},{"id":"https://openalex.org/C2776599063","wikidata":"https://www.wikidata.org/wiki/Q5282244","display_name":"Disinhibition","level":2,"score":0.4235125184059143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39440253376960754},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3531663119792938},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3033943176269531},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.19347190856933594},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07447069883346558},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008559","descriptor_name":"Memantine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008559","descriptor_name":"Memantine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020961","descriptor_name":"Lewy Body Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18577956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18577956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Comparative Study"},{"id":"mag:6973382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18577956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W2096235408","https://openalex.org/W1980746675","https://openalex.org/W2081453098","https://openalex.org/W1964535311","https://openalex.org/W2053283927","https://openalex.org/W2081960409","https://openalex.org/W2061448472","https://openalex.org/W2016953803","https://openalex.org/W1984637527","https://openalex.org/W2052187926","https://openalex.org/W2021873218","https://openalex.org/W2079956880","https://openalex.org/W2056638601","https://openalex.org/W1988067081"],"related_works":["https://openalex.org/W2062128885","https://openalex.org/W7020802383","https://openalex.org/W1699068791","https://openalex.org/W2129036744","https://openalex.org/W2163953162","https://openalex.org/W1972529729","https://openalex.org/W2118152780","https://openalex.org/W2030389734","https://openalex.org/W2103493089","https://openalex.org/W1848968105"],"abstract_inverted_index":{"Dementia":[0],"with":[1,14,30],"Lewy":[2],"bodies":[3],"(DLB)":[4],"is":[5,163],"a":[6,76],"progressive":[7],"disease":[8],"of":[9,26,37,75,81,92,130,137,139,153,161,174,176,182],"the":[10,97,110,123,128,171,179,183],"nervous":[11],"system":[12],"manifested":[13],"dementia,":[15],"parkinsonism,":[16],"psychotic":[17,95,156],"and":[18,24,72,94,132,155],"autonomic":[19],"disturbances.":[20],"To":[21],"estimate":[22],"efficacy":[23],"safety":[25],"memantine":[27,67,162],"in":[28,50,68],"patients":[29,64,74,167],"clinically":[31],"diagnosed":[32],"DLB":[33],"(according":[34],"to":[35,122,127],"criteria":[36],"McKeith":[38],"et":[39],"al.,":[40],"1999),":[41],"an":[42],"open":[43],"controlled":[44],"16-week":[45],"trial":[46],"was":[47,145],"carried":[48],"out":[49],"23":[51],"patients,":[52],"mean":[53,113],"age":[54],"69,2+/-5,9":[55],"years.":[56],"Patients":[57],"were":[58,102,116,149,168],"divided":[59],"into":[60],"2":[61,166],"groups:":[62],"14":[63],"who":[65],"received":[66],"dosage":[69],"20":[70],"mg/d":[71],"9":[73],"control":[77],"group.":[78],"A":[79],"battery":[80],"neuropsychological":[82],"tests,":[83],"clinical":[84],"assessment":[85,91],"using":[86],"fluctuation":[87],"scales,":[88],"scales":[89],"for":[90],"behavioral":[93],"disturbances,":[96],"General":[98],"Clinical":[99],"Impression":[100],"scale":[101],"used.":[103],"Memantine":[104],"significantly":[105],"improved":[106],"cognitive":[107],"dysfunction":[108],"throughout":[109],"study":[111,172],"(the":[112],"MMSE":[114],"scorer":[115],"increased":[117],"by":[118],"1,5":[119],"points":[120],"compared":[121],"baseline)":[124],"especially":[125],"due":[126],"improvement":[129],"attention":[131],"executive":[133],"functions.":[134],"The":[135],"reduction":[136],"fluctuations":[138],"mental":[140],"status,":[141],"aggressiveness,":[142],"aspontaneity,":[143],"disinhibition":[144],"also":[146],"observed.":[147],"There":[148],"no":[150],"significant":[151],"changes":[152],"Parkinsonian":[154],"symptoms":[157],"severity.":[158],"Good":[159],"tolerability":[160],"noted:":[164],"only":[165],"withdrawn":[169],"from":[170],"because":[173],"episodes":[175],"confusion":[177],"on":[178],"titration":[180],"phase":[181],"trial.":[184]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}